Improved treatment adherence through behavioural interventions among patients with chronic myeloid leukaemia

被引：0
|
作者：
Shajan, Sheena [1 ]
Surendran, V. [1 ]
Ganesan, Prasanth [1 ]
机构：
[1] Inst Canc Res, Chennai, Tamil Nadu, India
来源：
PSYCHO-ONCOLOGY | 2016年 / 25卷 / SP. S3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [31] Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
    Chen, Li-Chia
    Chen, Teng-Chou
    Huang, Yaw-Bin
    Chang, Chao-Sung
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (01) : 120 - 127
  • [32] Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
    Li-Chia Chen
    Teng-Chou Chen
    Yaw-Bin Huang
    Chao-Sung Chang
    International Journal of Clinical Pharmacy, 2014, 36 : 120 - 127
  • [33] Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia
    Ross, David M.
    Jackson, Sharon R.
    Browett, Peter J.
    LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1231 - 1233
  • [34] The interplay of knowledge, motivation, and treatment response in medication adherence among patients with chronic myeloid leukemia treated with Imatinib
    Omran, Mervat M.
    Ibrahim, Amel B.
    Abdelfattah, Raafat
    Moussa, Heba S.
    Shouman, Samia A.
    Hamza, Marwa S.
    LEUKEMIA & LYMPHOMA, 2025, 66 (01) : 123 - 130
  • [35] Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
    Al-Dewik, N. Ader I.
    Morsi, Hisham M.
    Samara, Muthanna M.
    Ghasoub, Rola S.
    Gnanam, Cinquea C.
    Bhaskaran, Subi K.
    Nashwan, Abdulqadir J.
    Al-Jurf, Rana M.
    Ismail, Mohamed A.
    AlSharshani, Mohammed M.
    AlSayab, Ali A.
    Ben-Omran, Tawfeg I.
    Khatib, Rani B.
    Yassin, Mohamed A.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 95 - 104
  • [36] Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia
    Daniels, J. M. A.
    Vonk-Noordegraaf, A.
    Janssen, J. J. W. M.
    Postmus, P. E.
    van Altena, R.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (03) : 670 - 672
  • [37] TREATMENT OF CHRONIC MYELOID LEUKAEMIA AND LYMPHORETICULAR SARCOMA WITH PIPOSULFAN
    SCHMIDT, M
    HAVEMANN, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (21) : 1166 - &
  • [38] Autografting as first line treatment for chronic myeloid leukaemia
    Singer, IO
    Franklin, IM
    JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (02) : 92 - 95
  • [39] First-line treatment of chronic myeloid leukaemia
    O'Dwyer, Michael
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2010, 1 (01) : 15 - 22
  • [40] State-of-the-art in the treatment of chronic myeloid leukaemia
    Milojkovic, Dragana
    Apperley, Jane
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (01) : 112 - 121
12345